Five Years of Steroid Sparing in Renal Transplantation with Tacrolimus and Mycophenolate Mofetil
Open Access
- 15 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 81 (1) , 125-128
Abstract
Steroid sparing with tacrolimus and mycophenolate mofetil (MMF) is associated with good short-term renal transplant outcomes. However, late allograft dysfunction and failure remain concerns. In this study, 101 consecutive patients underwent renal transplantation with tacrolimus, MMF, and 7 days of corticosteroids only. After a median follow-up of 51 months (range 36–62), overall patient survival is 97%, and overall survival with graft function is 91%. The acute rejection rate at 12 months was 19%. Late rejection was uncommon, with only three further episodes beyond 12 months. Graft function was stable during the study, with a mean creatinine of 140 μmol/L and mean estimated creatinine clearance of 57 ml/min at the end of follow-up. Six patients developed posttransplant diabetes mellitus (three cases beyond 12 months). This steroid avoidance regimen is associated with excellent medium-term patient and graft outcomes, and a low incidence of side effects.Keywords
This publication has 19 references indexed in Scilit:
- Steroid Avoidance Versus Steroid Withdrawal After Simultaneous Pancreas-Kidney TransplantationAmerican Journal of Transplantation, 2005
- New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantationKidney International, 2005
- A Multicenter Pilot Study of Early (4-Day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus and SirolimusAmerican Journal of Transplantation, 2005
- Steroid-Withdrawal at 3 Days After Renal Transplantation with Anti-IL-2 Receptor α Therapy: A Prospective, Randomized, Multicenter StudyAmerican Journal of Transplantation, 2004
- What's New and What's Hot in Transplantation: Clinical Science ATC 2003American Journal of Transplantation, 2003
- Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation1Transplantation, 2003
- Multicenter Randomized Prospective Trial of Steroid Withdrawal in Renal Transplant Recipients Receiving Basiliximab, Cyclosporine Microemulsion and Mycophenolate MofetilAmerican Journal of Transplantation, 2003
- Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot studyTransplantation, 2002
- Hypertension and long‐term renal allograft survival: effect of early glomerular filtration rateNephrology Dialysis Transplantation, 2001
- CHOLESTEROL AS AN INDEPENDENT PREDICTOR OF OUTCOME AFTER RENAL TRANSPLANTATIONTransplantation, 2000